Toll-like receptor 2 on inflammatory monocytes induces type i interferon in response to viral but not bacterial ligands

Nature Immunology

Volumn 10, Issue 11, 2009, Pages 1200-1209

  Barbalat, Roman ^a   Lau, Laura ^a   Locksley, Richard M ^b   Barton, Gregory M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11 ANTIGEN; INTERFERON; LIGAND; TLR2 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2;

ANIMAL; ARTICLE; C57BL MOUSE; CELL LINE; CYTOLOGY; FLOW CYTOMETRY; HAMSTER; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MONOCYTE; MOUSE; SIGNAL TRANSDUCTION; SPLEEN; VACCINIA; VACCINIA VIRUS; VIROLOGY;

ANIMALS; ANTIGENS, CD11; CELL LINE; CRICETINAE; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; LIGANDS; MICE; MICE, INBRED C57BL; MONOCYTES; SIGNAL TRANSDUCTION; SPLEEN; TOLL-LIKE RECEPTOR 2; VACCINIA; VACCINIA VIRUS;

EID: 70350441863     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1792     Document Type: Article

References (56)

1. Medzhitov, R. Recognition of microorganisms and activation of the immune response. Nature 449, 819-826 (2007).
2. Kawai, T. and Akira, S. Innate immune recognition of viral infection. Nat. Immunol. 7, 131-137 (2006).
3. Burckstummer, T. et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat. Immunol. 10, 266-272 (2009).
4. Fernandes-Alnemri, T., Yu, J.W., Datta, P., Wu, J. and Alnemri, E.S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 509-513 (2009).
5. Hornung, V. et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514-518 (2009).
6. Roberts, T.L. et al. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323, 1057-1060 (2009).
7. Stetson, D.B. and Medzhitov, R. Type I interferons in host defense. Immunity 25, 373-381 (2006).
8. van den Broek, M.F., Muller, U., Huang, S., Zinkernagel, R.M. and Aguet, M. Immune defence in mice lacking type I and/or type II interferon receptors. Immunol. Rev. 148, 5-18 (1995).
9. Gilliet, M., Cao, W. and Liu, Y.J. Plasmacytoid dendritic cells: Sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8, 594-606 (2008).
10. Kadowaki, N. et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194, 863-869 (2001).
11. Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640-643 (2003).
12. Auerbuch, V., Brockstedt, D.G., Meyer-Morse, N., O’Riordan, M. and Portnoy, D.A. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 200, 527-533 (2004).
13. O’Connell, R.M. et al. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J. Exp. Med. 200, 437-445 (2004).
14. Boehme, K.W., Guerrero, M. and Compton, T. Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J. Immunol. 177, 7094-7102 (2006).
15. Compton, T. et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 77, 4588-4596 (2003).
16. Szomolanyi-Tsuda, E., Liang, X., Welsh, R.M., Kurt-Jones, E.A. and Finberg, R.W. Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J. Virol. 80, 4286-4291 (2006).
17. Sato, A., Linehan, M.M. and Iwasaki, A. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc. Natl. Acad. Sci. USA 103, 17343-17348 (2006).
18. Kurt-Jones, E.A. et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. USA 101, 1315-1320 (2004).
19. Chang, S., Dolganiuc, A. and Szabo, G. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J. Leukoc. Biol. 82, 479-487 (2007).
20. Zhou, S. et al. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 35, 822-830 (2005).
21. Bieback, K. et al. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J. Virol. 76, 8729-8736 (2002).
22. Zhu, J., Martinez, J., Huang, X. and Yang, Y. Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta. Blood 109, 619-625 (2007).
23. Toshchakov, V. et al. TLR4, but not TLR2, mediates IFN-p-induced STAT1a/p-dependent gene expression in macrophages. Nat. Immunol. 3, 392-398 (2002).
24. Kawai, T. et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167, 5887-5894 (2001).
25. Doyle, S. et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17, 251-263 (2002).
26. Krug, A. et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21, 107-119 (2004).
27. Tabeta, K. et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 7, 156-164 (2006).
28. Ablasser, A. et al. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat. Immunol. 10, 1065-1072 (2009).
29. Chiu, Y.-H., MacMillan, J.B. and Chen, Z.J. RNA polymerase III detects cytosolic DNA and induces type interferons through the RIG-I pathway. Cell 138, 576-591 (2009).
30. Asselin-Paturel, C. et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2, 1144-1150 (2001).
31. Jin, M.S. et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130, 1071-1082 (2007).
32. Scheu, S., Dresing, P. and Locksley, R.M. Visualization of I FNp production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo. Proc. Natl. Acad. Sci. USA 105, 20416-20421 (2008).
33. Okusawa, T. et al. Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by Toll-like receptors 2 and 6. Infect. Immun. 72, 1657-1665 (2004).
34. Cailhier, J.F. et al. Conditional macrophage ablation demonstrates that resident macrophages initiate acute peritoneal inflammation. J. Immunol. 174, 2336-2342 (2005).
35. Auffray, C., Sieweke, M.H. and Geissmann, F. Blood monocytes: Development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27, 669-692 (2009).
36. Geissmann, F., Jung, S. and Littman, D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82 (2003).
37. Serbina, N.V., Jia, T., Hohl, T.M. and Pamer, E.G. Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26, 421-452 (2008).
38. Kagan, J. et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-p. Nat. Immunol. 9, 361-368 (2008).
39. Lee, P.Y. et al. A novel type I IFN-producing cell subset in murine lupus. J. Immunol. 180, 5101-5108 (2008).
40. Krieg, A.M. Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 5, 471-484 (2006).
41. Ishii, K.J. et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7, 40-48 (2006).
42. Stetson, D.B. and Medzhitov, R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24, 93-103 (2006).
43. Takaoka, A. et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448, 501-505 (2007).
44. Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099-1103 (2001).
45. Franchi, L. et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1-p in salmonella-infected macrophages. Nat. Immunol. 7, 576-582 (2006).
46. Miao, E.A. et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1-p via Ipaf. Nat. Immunol. 7, 569-575 (2006).
47. Lightfield, K.L. et al. Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin. Nat. Immunol. 9, 1171-1178 (2008).
48. Smith, K.D. et al. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat. Immunol. 4, 1247-1253 (2003).
49. Steven, A.C. and Spear, P.G. Biochemistry. Viral glycoproteins and an evolutionary conundrum. Science 313, 177-178 (2006).
50. Kurt-Jones, E.A. et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1, 398-401 (2000).
51. Jude, B.A. et al. Subversion of the innate immune system by a retrovirus. Nat. Immunol. 4, 573-578 (2003).
52. Triantafilou, K. and Triantafilou, M. Coxsackievirus B4-induced cytokine production in pancreatic cells is mediated through toll-like receptor 4. J. Virol. 78, 11313-11320 (2004).
53. Georgel, P. et al. Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. Virology 362, 304-313 (2007).
54. Jiang, Z. et al. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 6, 565-570 (2005).
55. Crimmins, G.T. et al. Listeria monocytogenes multidrug resistance transporters activate a cytosolic surveillance pathway of innate immunity. Proc. Natl. Acad. Sci. USA 105, 10191-10196 (2008).
56. Ewald, S.E. et al. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456, 658-662 (2008).